stockportfolio.pro
Stocks / CRMD vs SIBN
CRMD vs SIBN
CorMedix Inc. and SI-BONE, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| CorMedix Inc. (CRMD) | SI-BONE, Inc. (SIBN) | |
|---|---|---|
| Market cap | $0.7B | $0.7B |
| Revenue (latest FY) | $311.71M | $200.93M |
| Net income (latest FY) | $163.06M | $-18.90M |
| Revenue growth (5y CAGR) | 319.7% | 22.3% |
| Net margin | 52.3% | -9.4% |
| Return on equity | 40.2% | -10.6% |
| P/E ratio | 4.1 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CRMD — free Open SIBN — freeFrequently asked questions
Which is bigger, CRMD or SIBN?
CorMedix Inc. is larger by market capitalization — $0.7B versus $0.7B.
Which grows faster, CRMD or SIBN?
Over the last five fiscal years, CorMedix Inc. grew revenue faster — 319.7%/yr versus 22.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.